Shenni Holdings, which makes and sells urology medical devices and products in China, filed on Friday with the SEC to raise up to $15 million in an initial public offering.
The Jian, China-based company plans to raise $15 million by offering 3 million shares at a price range of $4 to $6. At the midpoint of the proposed range, Shenni Holdings would command a market value of $165 million.
Through its operating subsidiaries in China, Shenni Holdings primarily engages in the manufacture and distribution of urology medical devices and care products, as well as the distribution of cardiovascular and cerebrovascular medical devices. Key urology medical device products include guide wires, catheter sheaths, and PTA balloon catheters. Key cardio and cerebrovascular products include catheters, guide wires, stents, and embolization products.
Shenni Holdings was founded in 2002 and booked $21 million in sales for the 12 months ended September 30, 2024. It plans to list on the Nasdaq under the symbol SNI. The company filed confidentially on November 15, 2024. D. Boral Capital is the sole bookrunner on the deal.
